20:03 EST Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals (RXRX) today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Unusually active option classes on open November 20th
- Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
- Recursion, Exscientia officially combine to advance drug discovery
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Recursion, Exscientia shareholders approve proposed combination